Impact of atopic dermatitis on the quality of life of children and their families

Đurović, Milena Ražnatović; Janković, Janko; Ćirković, Andja; Timotijević, Zorica Sojević; Julijana, Rašić; Leonida, Vitković; Spirić, Vesna Tomić; Janković, Slavenka

doi:10.23736/s2784-8671.19.06447-2

Cited by 7 publications

(8 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The CDLQI questionnaire completed by patients was positively correlated with the severity of disease, showing a trend similar to atopic dermatitis and psoriasis 19 20 . The mDFI questionnaire completed by family members showed similar results; pediatric AA, like atopic dermatitis, affects the QoL of family members 21 .…”

Section: Discussionmentioning

confidence: 74%

Impact of Pediatric Alopecia Areata on Quality of Life of Patients and Their Family Members: A Nationwide Multicenter Questionnaire Study

et al. 2022

View full text Add to dashboard Cite

Background Pediatric alopecia areata (AA) can affect the quality of life (QoL) of patients and their family members. Research on the QoL and burden on family members in pediatric AA is limited. Objective This nationwide multicenter questionnaire study described the QoL and burden of the family members of patients with pediatric AA. Methods This nationwide multicenter questionnaire study enrolled AA patients between the ages of 5 and 18 years from March 1, 2017 to February 28, 2018. Enrolled patients and their parents completed the modified Children’s Dermatology Life Quality Index (CDLQI) and the modified Dermatitis Family Impact (mDFI). The disease severity was measured using the Severity of Alopecia Tool (SALT) survey scores. Results A total of 268 patients with AA from 22 hospitals participated in this study. Our study found that the efficacy and satisfaction of previous treatments of AA decreased as the severity of the disease increased. The use of home-based therapies and traditional medicines increased with the increasing severity of the disease, but the efficacy felt by patients was limited. CDLQI and mDFI scores were higher in patients with extensive AA than those with mild to moderate AA. The economic and time burden of the family members also increased as the severity of the disease increased. Conclusion The severity of the AA is indirectly proportional to the QoL of patients and their family members and directly proportional to the burden. Physicians need to understand these characteristics of pediatric AA and provide appropriate intervention to patients and their family members.

show abstract

Section: Discussionmentioning

confidence: 74%

Impact of Pediatric Alopecia Areata on Quality of Life of Patients and Their Family Members: A Nationwide Multicenter Questionnaire Study

et al. 2022

View full text Add to dashboard Cite

show abstract

“…42 The intangible burden of AD on the daily lives of patients and their families is extensive and complex Moderate-to-severe AD carries a substantial physical and psychological burden that negatively impacts patients' and families' lives, such as their relationships, social activities, work and emotional wellbeing. 10,11,30,41,44,50,51,52,53,54,55,56,57,58,59 In particular, anxiety, depression, and social isolation are widely experienced in those with AD. 31 Furthermore, a higher risk of suicide ideation, and even attempts, has been reported in patients with AD compared to those without the disease.…”

Section: See Supplementary Materialsmentioning

confidence: 99%

“…[61][62][63] The vicious itch-scratch cycle has been considered the largest contributor to QoL impacts in patients and family members. 51,57,64,65 This can cause chronic sleep disruption, which leads to emotional and behavioural problems, difficulties with daytime functioning and work performance, and can have an impact on sexual health. 10,66,67 For children and adolescents, the physical and emotional effects of this cycle can be particularly disruptive during their critical years of development, impacting school performance, preventing them from taking part in school, sports and social activities, and hindering them forming relationships due to bullying, social stigmatisation and feelings of low self-esteem.…”

Section: See Supplementary Materialsmentioning

confidence: 99%

“…Moderate‐to‐severe AD carries a substantial physical and psychological burden that negatively impacts patients' and families' lives, such as their relationships, social activities, work and emotional wellbeing 10,11,30,41,44,50,51,52,53,54,55,56,57,58,59 . In particular, anxiety, depression, and social isolation are widely experienced in those with AD 31 .…”

Section: The Impact or Burden Of Moderate‐to‐severe Ad Is Extensive A...mentioning

confidence: 99%

“…The vicious itch–scratch cycle has been considered the largest contributor to QoL impacts in patients and family members 51,57,64,65 . This can cause chronic sleep disruption, which leads to emotional and behavioural problems, difficulties with daytime functioning and work performance, and can have an impact on sexual health 10,66,67 .…”

Section: The Impact or Burden Of Moderate‐to‐severe Ad Is Extensive A...mentioning

confidence: 99%

See 2 more Smart Citations

Unveiling the true costs and societal impacts of moderate‐to‐severe atopic dermatitis in Europe

Augustin

Miséry

Kobyletzki

et al. 2022

Acad Dermatol Venereol

View full text Add to dashboard Cite

Atopic dermatitis (AD) is a chronic, auto‐immune condition that imposes a high burden on individuals, society, and the healthcare system. Approximately 4.4% of adults and up to 18.6% of children/adolescents have AD in Europe, with 20% of all cases accounting for moderate‐to‐severe forms. This form of the condition in adults results in annual societal costs across Europe of an estimated €30 billion; €15.2 billion related to missed workdays or reduced work productivity, €10.1 billion related to direct medical costs and €4.7 billion related to personal expenditure of patients/families. AD can also substantially impact physical, emotional, and social quality‐of‐life. Several studies have shown the debilitating itch‐scratch cycle is the main cause of the multifaceted burden, as it causes substantial sleep deprivation and stigmatisation due to the physical appearance of the skin, and confidence issues. These factors lead to psychosocial issues and can cumulate over time and prohibit patients reaching their ‘full life potential’. Despite this, many patients with the condition are undertreated, resulting in uncontrolled symptoms and a further strain placed on patients, society, and the economy. The authors of this White Paper comprise the European Atopic Dermatitis Working Group, which is a network of international specialists with expertise in dermatology and healthcare policy decisions. Their programme of action is focused on harnessing their expertise to build consensus, advance research, share knowledge, and ultimately seek to improve AD care outcomes through achieving long‐term symptom control. This White Paper presents a systematic evaluation of the overall financial and humanistic burden of moderate‐to‐severe AD and the current challenges that exist with AD care. It introduces recommendations for how, collaboratively, key stakeholders and policy makers can support improvements in AD management to achieve better disease control, thus reducing the costs and associated burden placed on individuals, society, and the economy.

show abstract

Atopi̇c Dermati̇ti̇s as a Cause of Impari̇ed Quali̇ty of Li̇fe İn Chi̇ldren and Maternal Anxi̇ety and Depressi̇on Symptoms

tunca,

Yilmaz,

Alkin

et al. 2024

Preprint

View full text Add to dashboard Cite

Aim: Atopic dermatitis (AD), a chronic inflammatory skin condition which can cause severe psychosocial problems. We aimed to assess the connection between qaulity of life in children wiith atopic dermatitis and maternal anxiety and depression symptoms. Methods: This study was prospective and was conducted at our Pediatric Allergy outpatient department. Atopic dermatitis severity was assessed using the SCORAD score. The mothers were asked to fill in the State-Trait Anxiety Scales (STAI-1, STAI-2) and Beck Depression Scale during the outpatient visit for the child. For children unders four years of age, the mothers were asked to fill in the 10 item infant dermatitis quality of life (IDQL) questionnaire. For children aged four and older, one of the researcher assisted the child to fill in the 10 item quality of life scale (CDLQI). At one-month follow-up, STAI-1 and STAI-2 and Beck Depression Scale were administered again as well as the IDQL or CDLQI depending on the age of the child. . Results: 90 mother-child pairs were enrolled. According to the SCORAD index, at enrollement 10 cildren had mild, 62 chldren had moderate and 18 children had severe disease and this regressed to mild disease for all children at one-month follow up. (p<0.001). According to the SCORAD index, there was a significant relationship between the quality of life of children and their mothers' depression evaluations. According to the Beck Depression Scale, 69 mothers had minimal and 11 mothers had mild, depression whil 1 had severe depression. With the improvement of the SCORAD index, a significant improvement was observed in the maternal Beck Depression Scale score. Similarly, STAI-1 and STAI-2 scores alse improved (p<0.001) Conclusion: Both the quality of life scores of the chldren and maternal anxiety and depression scores are associatd with disease severity.

show abstract

Impact of atopic dermatitis on the quality of life of children and their families

Cited by 7 publications

References 27 publications

Impact of Pediatric Alopecia Areata on Quality of Life of Patients and Their Family Members: A Nationwide Multicenter Questionnaire Study

Impact of Pediatric Alopecia Areata on Quality of Life of Patients and Their Family Members: A Nationwide Multicenter Questionnaire Study

Unveiling the true costs and societal impacts of moderate‐to‐severe atopic dermatitis in Europe

Atopi̇c Dermati̇ti̇s as a Cause of Impari̇ed Quali̇ty of Li̇fe İn Chi̇ldren and Maternal Anxi̇ety and Depressi̇on Symptoms

Contact Info

Product

Resources

About